Minerals in the News
from The Mineral People™
Vol 4, Issue 7, July 2006

 

 

Magnesium and the inflammatory response: Potential physiopathological implications.
Mazur A, et al.
Arch Biochem Biophys. 2006 Apr 19.

The purpose of this review is to summarize experimental findings showing that magnesium modulates cellular events
involved in inflammation. Experimental magnesium deficiency in the rat induces a clinical inflammatory syndrome
characterized by leukocyte and macrophage activation, release of inflammatory cytokines and acute phase proteins, excessive production of free radicals. Increase in extracellular magnesium concentration, decreases inflammatory response, while reduction in the extracellular magnesium results in cell activation. Because magnesium acts as a natural calcium antagonist, the molecular basis for inflammatory response is probably the result of modulation of intracellular calcium concentration. Magnesium deficiency induces a systemic stress response by activation of neutron endocrinological pathways. As nervous and immune systems interact directionally, the roles of neuromediators have also been considered. Magnesium deficiency contributes to an exaggerated response to immune stress and oxidative stress as the consequence of the inflammatory response. Inflammation contributes to the proatherogenic changes in lipoprotein metabolism, endothelial dysfunction, thrombosis, hypertension, and explains the aggravating effect of magnesium deficiency on the development of metabolic syndrome. Further studies are still needed to assess more accurately the role of magnesium in immune response in humans, but these experimental findings in animal models suggest that inflammation is the missing link to explain the role of magnesium in many pathological conditions.


 

 

Oral magnesium administration prevents thermal hyperalgesia induced by diabetes in
rats.

Hasanein P, et al.
Diabetes Res Clin Pract. 2006 Jul;73(1):17-22.
 

Peripheral neuropathy is a common complication of diabetes mellitus. It has been shown that hyperglycemia may contribute to its development but the exact pathophysiology underlying this complication is not fully understood. Since oral magnesium supplementation can normalize hyperglycemia induced by diabetes in rats, this study was designed to examine the effect of oral magnesium administration on thermal hyperalgesia (pain hypersensitivity) in streptozocin-induced diabetic rats. Twenty-four male adult wistar rats were divided equally into control, magnesium-treated control, diabetic and magnesium-treated diabetic groups. In magnesium-treated diabetic rats, magnesium sulfate was added into the drinking water once diabetes was established and continued for 8 weeks. Magnesium-treated control animals received magnesium sulfate in the same dose and over the same time period. The other two groups; control and diabetic animals, only received tap water. At the end of the 8 weeks, thermal pain threshold was assessed by tail flick test and magnesium and glucose plasma levels were measured in all groups. A significant decrease in thermal pain threshold and plasma magnesium levels and an increase in plasma glucose levels were seen in diabetic rats 8 weeks after diabetes induction. After 8 weeks of oral magnesium, thermal hyperalgesia was normalized and plasma magnesium and glucose levels were restored towards normal. It is concluded that oral magnesium administration given at the time of diabetes induction may be able to restore thermal hyperalgesia, magnesium deficiency and hyperglycemia and in diabetic rats.

 

Bioavailability of zinc glycinate in comparison with zinc sulphate in the presence of
dietary phytate in an animal model with Zinc labeled rats.

Schlegel P, and Windisch W.
J Anim Physiol Anim Nutr (Berl). 2006 Jun;90(5-6):216-22.
 

The objective of this study was to quantify the bioavailability of zinc (Zn) from sulphate and glycinate as representatives of inorganic and organic zinc sources. The semi-synthetic basal diet contained 2 mug/g of native Zn and was fortified with pure sodium-phytate (8g/kg) in order to simulate conditions of common cereal-based meals. The basal diet was supplemented with either 53 mug/g of Zn from sulphate (control) or 10 mug/g of Zn from either sulphate (ZnSulphate) or glycinate (ZnGly). Twenty-four (65) Zn-labelled, growing rats weighing 133 g were allotted to the three diets (eight animals pretreatment) and were kept pair-fed to ZnSulphate for 15 days. Zn contents in blood plasma, femur and whole body, as well as, plasma alkaline phosphatase activites were reduced compared with control indicating zinc deficiency in ZnSulphate and ZnGly treatment. This allowed their differentiation in zinc bioavailability. True absorption of dietary Zn was significantly higher in ZnGly than in ZnSulphate (51% vs. 44%) while losses of endogenous faecal Zn and urinary Zn were not affected to a quantitatively relevant extent. This resulted in a +30% significantly improved Zn retention for ZnGly (33% vs. 25%) and a lower severity on Zn deficiency symptoms compared with ZnSulphate. Metabolic utilization accounted for 95% of absorbed dietary Zn for both Zn sources. Overall, the bioavailability of zinc glycinate was significantly superior by 16% to zinc sulphate (49% vs. 42%), mainly because of a higher absorptive potential at presence of a strong antinutritive component (phytate) in the diet.

 

Zinc status in infantile wheezing.
Tahan F, and Karakukcu C..
Pediatr Pulmonol. 2006 Jul;41(7):630-4.
 

The increase in prevalence of asthma is strongly dependent on environmental factors, including diet. Significant decreases in the intake of dietary zinc may be an important contributing factor to the increasing incidence of wheezing and asthma, but there have been no studies evaluating zinc levels in wheezy infants. Our objective was to investigate the zinc status of wheezy infants. Wheezy infants (n = 34) and healthy children (n = 14) were included in the study. Total IgE and eosinophil counts were obtained, and skin testing was done with a battery of 25 antigens with appropriate positive and negative controls. Levels of zinc were determined in hair. No significant difference was observed in peripheral blood eosinophil counts and total IgE levels among groups. Hair zinc levels were significantly lower in wheezy infants (P < 0.001). In conclusion, hair zinc levels were lower in wheezy infants than in healthy controls, suggesting that zinc deficiency may influence the risk of wheezing in early childhood.

 

Rapid recovery from major depression using magnesium treatment.
Eby GA, Eby KL.
Med Hypotheses. 2006 Mar 14; [Epub ahead of print]

Major depression is a mood disorder characterized by a sense of inadequacy, despondency, decreased activity, pessimism, anhedonia and sadness where these symptoms severely disrupt and adversely affect the person's life, sometimes to such an extent that suicide is attempted or results. Antidepressant drugs are not always effective and some have been accused of causing an increased number of suicides particularly in young people. Magnesium deficiency is well known to produce neuropathologies. Only 16% of the magnesium found in whole wheat remains in refined flour, and magnesium has been removed from most drinking water supplies, setting a stage for human magnesium deficiency. Magnesium ions regulate calcium ion flow in neuronal calcium channels, helping to regulate neuronal nitric oxide production. In magnesium deficiency, neuronal requirements for magnesium may not be met, causing neuronal damage which could manifest as depression. Magnesium treatment is hypothesized to be effective in treating major depression resulting from intraneuronal magnesium deficits. These magnesium ion neuronal deficits may be induced by stress hormones, excessive dietary calcium as well as dietary deficiencies of magnesium. Case histories are presented showing rapid recovery (less than 7 days) from major depression using 125-300mg of magnesium (as glycinate and taurinate) with each meal and at bedtime. Magnesium was found usually effective for treatment of depression in general use. Related and accompanying mental illnesses in these case histories including traumatic brain injury, headache, suicidal ideation, anxiety, irritability, insomnia, postpartum depression, cocaine, alcohol and tobacco abuse, hypersensitivity to calcium, short-term memory loss and IQ loss were also benefited.
Dietary deficiencies of magnesium, coupled with excess calcium and stress may cause many cases of other related symptoms including agitation, anxiety, irritability, confusion, asthenia, sleeplessness, headache, delirium, hallucinations and hyperexcitability, with each of these having been previously documented. The possibility that magnesium deficiency is the cause of most major depression and related mental health problems including IQ loss and addiction is enormously important to public health and is recommended for immediate further study. Fortifying refined grain and drinking water with biologically available magnesium to pre-twentieth century levels is recommended.

 

Effects of zinc supplementation on 1- to 5-year old children.
Zilva AP, Vitolo MR, Zara LF, Castro CF.
Pediatr (Rio J), 2006 May 26;82(3).
 

To assess the impact of zinc supplementation on nutritional and biochemical parameters among children aged 12 to 59 months. A blinded randomized clinical trial was carried out with 58 children aged 12 to 59 months included in the National Child Nutritional Program, which provided them with 2 kg of iron-fortified milk. The supplementation group (n = 28) received 10 mg/day of zinc sulfate for four months, and the control group (n = 30) received placebo. The following
parameters were used to assess the nutritional status: weight-for-height and height-for-age expressed as z scores, according to National Center for Health Statistics standards, biochemical measurements of serum iron and serum zinc, and hemoglobin and hematocrit levels. Zinc supplementation did not have a remarkable influence on anthropometric parameters. Baseline serum zinc levels were low in both groups. After supplementation, variations in mean hemoglobin, hematocrit, serum zinc, and serum iron levels significantly increased in the zinc supplementation group. Zinc supplementation improved hemoglobin response and normalized serum zinc concentration. The results show the importance of establishing policies for nutritional care that can tackle zinc deficiency as well.